CRISPR-based system identifies drug targets in AML – Drug Target Review
Drug Target Review |
CRISPR-based system identifies drug targets in AML
Drug Target Review Scientists have discovered a way to rein in an overactive protein that drives some aggressive leukaemias. The renegade molecule, MEF2C, belongs to a class of proteins that is notoriously difficult to manipulate with drugs. But the new research suggests … |
